Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:(%22Test toxicit%C3%A9%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 213300

  • Page / 8532
Export

Selection :

  • and

Internalization of Coxsackievirus A9 Is Mediated by β2-Microglobulin, Dynamin, and Arf6 but Not by Caveolin-1 or ClathrinHEIKKILÄ, Outi; SUSI, Petri; TEVALUOTO, Tuire et al.Journal of virology. 2010, Vol 84, Num 7, pp 3666-3681, issn 0022-538X, 16 p.Article

Preliminary crystallographic analysis of coxsackievirus A9SMYTH, M; HALL, J; FRY, E et al.Journal of molecular biology. 1993, Vol 230, Num 2, pp 667-669, issn 0022-2836Article

Integrin αVβ6 is a high-affinity receptor for coxsackievirus A9HEIKKILÄ, Outi; SUSI, Petri; STANWAY, Glyn et al.Journal of general virology. 2009, Vol 90, pp 197-204, issn 0022-1317, 8 p., 1Article

Factors affecting virus plaque confirmation proceduresDAHLING, D. R; SULLIVAN, G; FREYBERG, R. W et al.Journal of virological methods. 1989, Vol 24, Num 1-2, pp 111-122, issn 0166-0934Article

Efficient RGD-independent entry process of coxsackievirus A9ROIVAINEN, M; PIIRAINEN, L; HOVI, T et al.Archives of virology. 1996, Vol 141, Num 10, pp 1909-1919, issn 0304-8608Article

A CASE OF COXSACKIE A9 VIRUS INFECTION WITH ORCHITISWILLEMS WR; HORNIG C; BAUER H et al.1978; J. MED. VIROL.; USA; DA. 1978; VOL. 3; NO 2; PP. 137-140; BIBL. 8 REF.Article

A combined method for rescue of modified enteroviruses by mutagenic primers, long PCR and T7 RNA polymerase-driven in vivo transcriptionHEIKKILÄ, Outi; KAINULAINEN, Markus; SUSI, Petri et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 129-133, issn 0166-0934, 5 p.Article

Safety of glucocorticoids - clinical trialsDA SILVA, J. A. P.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 5, issn 0392-856X, S99-S103, SUP68Article

FREISETZUNG ZELLULAERER ENZYME WAEHREND DER VERMEHRUNG VON COXSACKIEVIRUS A9 IN FL-ZELLEN. II.ABHAENGIGKEIT DER ENZYMFREISETZUNG VON ZELLDICHTE, VIRUSKONZENTRATION, PH-WERT UND SERUMGEHALT DES INKUBATIONSMEDIUMS = LIBERATION DE L'ENZYME CELLULAIRE AU COURS DE LA MULTIPLICATION DU COXSACKIEVIRUS A9 EN CELLULES FL. II.INFLUENCE DU NOMBRE DE CELLULES, DE LA CONCENTRATION DE VIRUS, DU PH ET DE LA TENEUR EN SERUM DU MILIEU DE CULTURE SUR CETTE LIBERATIONKLOCKING R; SCHWEIZER H; SPROSSIG M et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 3-4; PP. 353-359; ABS. ANGL.; BIBL. 10REF.Article

A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virionsROIVAINEN, Merja; ALAKULPPI, Noora; YLIPAASTO, Petri et al.Journal of virological methods. 2005, Vol 130, Num 1-2, pp 108-116, issn 0166-0934, 9 p.Article

Photoinactivation of three viruses by rose bengalLEWIS, A. L; WELLINGS, F. M; MARTIN, D. F et al.Journal of environmental science and health. Part A, Environmental science and engineering. 1988, Vol 23, Num 2, pp 127-137, issn 0360-1226Article

In vivo effects of vitamin C on the cytotoxicity of post-ethanol serumWICKRAMASINGHE, S. N; HASAN, R.Biochemical pharmacology. 1994, Vol 48, Num 3, pp 621-624, issn 0006-2952Article

STUDIES ON THE INTERACTION BETWEEN COXSACKIEVIRUS A9 AND HELA CELLS. I. PLAQUE-FORMING ABILITY OF COXSACKIEVIRUS A9 IN HELA CELL CULTURES.MATSUMOTO M; NAKANO M; NISHIKAWA F et al.1976; JAP. J. MED. SCI. BIOL.; JAP.; DA. 1976; VOL. 29; NO 2; PP. 67-76; BIBL. 15 REF.Article

Complement activation by diesel exhaust particles (DEP)KANEMITSU, H; NAGASAWA, S; SAGAI, M et al.Biological & pharmaceutical bulletin. 1998, Vol 21, Num 2, pp 129-132, issn 0918-6158Article

Estudio immunologico de niños residentes en una comunidad expuesta a la utilizacion intensiva de plaguicidas con fines agricolasPABLO DIEZ CORDOVA, J; DIAZ FERNANDEZ, A. M; DE ARMA JIMENEZ, M et al.Revista cubana de pediatría. 1991, Vol 63, Num 2, pp 94-99, issn 0034-7531Article

Effect of iodinated contrast media on a radioimmunoassay of C3aEATON, S; TSAY, H. M; YOST, F et al.Clinical chemistry (Baltimore, Md.). 1987, Vol 33, Num 8, issn 0009-9147, 1470Article

A novel one-step oxidation of terminal epoxides to allylic aldehydesWILLIS, C. L.Tetrahedron letters. 1987, Vol 28, Num 19, pp 2175-2178, issn 0040-4039Article

Inhibition of complement components C3 and C4 by cadralazine and its active metaboliteANDERSSON, M; HANSON, A; ENGLUND, G et al.European journal of clinical pharmacology. 1991, Vol 40, Num 3, pp 261-265, issn 0031-6970, 5 p.Article

The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classificationKI HA CHANG; AUVINEN, P; HYYPIA, T et al.Journal of general virology. 1989, Vol 70, Num 12, pp 3269-3280, issn 0022-1317Article

CONSTRUCTION OF VIABLE MOUSE-HUMAN HYBRID CELLS BY NUCLEAR TRANSPLANTATIONHIGHTOWER MJ; LUCAS JJ.1980; J. CELL. PHYSIOL.; ISSN 0021-9541; USA; DA. 1980; VOL. 105; NO 1; PP. 93-103; BIBL. 26 REF.Article

CHEMOTACTIC ACTIVITY OF VENOM FROM THE BROWN RECLUSE SPIDER (LOXOSCELES RECLUSA)GEBEL HM; CAMPBELL BJ; BARRETT JT et al.1979; TOXICON; GBR; DA. 1979; VOL. 17; NO 1; PP. 55-60; BIBL. 16 REF.Article

ETUDE DU VACCIN INACTIVE ASSOCIE CONTRE LES COXSACKIEVIRUS A9 ET B1 ET ECHOVIRUS 6BIERNACKI M; JABLONSKI L.1974; MED. DOSW. MIKROBIOL.; POLSKA; DA. 1974; VOL. 26; NO 4; PP. 339-350; ABS. RUSSE ANGL.; BIBL. 6REF.Article

PINOCYTOTIC UPTAKE AND INTRALYSOSOMAL CRYSTAL FORMATION OF COXSACKIEVIRUS A9 IN MONKEY KIDNEY CELLS. AN ELECTRON MICROSCOPIC AUTORADIOGRAPHIC STUDY = ABSORPTION PAR PINOCYTOSE ET FORMATION DE CRISTAUX A L'INTERIEUR DE LYSOSOMES DANS LE CAS DU COXSACKIEVIRUS A9 EN CELLULES RENALES DE SINGE. AUTORADIOGRAPHIE ETUDIEE AU MICROSCOPE ELECTRONIQUEHECKER W; MEYER J; BOENI R et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 1-2; PP. 167-174; BIBL. 2P.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

SYNTHESIS OF THE LABELED GIBBERELLIN, GA9-17-14CJIANN TSYH LIN; HEFTMANN E.1979; J. LABELL. COMPOUNDS RADIOPHARM.; GBR; DA. 1979; VOL. 16; NO 4; PP. 537-545; BIBL. 17 REF.Article

  • Page / 8532